Suvretta Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-30,500
| Closed | -$1.06M | – | 108 |
|
|
2024
Q2 | $1.06M | Hold |
30,500
| – | – | 0.04% | 77 |
|
|
2024
Q1 | $882K | Buy |
+30,500
| New | +$882K | 0.03% | 87 |
|
|
2023
Q4 | – | Sell |
-108,308
| Closed | -$1.81M | – | 95 |
|
|
2023
Q3 | $1.81M | Buy |
108,308
+27,165
| +33% | +$453K | 0.1% | 66 |
|
|
2023
Q2 | $2.24M | Buy |
+81,143
| New | +$2.24M | 0.12% | 74 |
|